NEW
Stock Screener with Intrinsic Value
Summit Therapeutics Inc. (SMMT)
Last Price$19.04.6%
Market Cap$13.8B
N/A
Industry median - 13.2%
5Y Historical average - (10.5%)
N/A
Industry median - 1.0%
5Y Historical average - 44.1%
(93.6%)
Industry median - (20.6%)
5Y Historical average - 128.3%
120.3%
Industry median - (1.2%)
5Y Historical average - 45.9%
SMMT Growth Rating
Crunching data... Almost there!
SMMT Growth Metrics
Crunching data... Almost there!
Competing with SMMT Growth
Overview
Ratings
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Summit Therapeutics Inc. (SMMT) revenue growth?
The Summit Therapeutics Inc. (SMMT) revenue growth is N/A, which is lower than the industry median of 13.2% and the 5-year historical average of (10.5%).
What is the Summit Therapeutics Inc. (SMMT) operating income growth?
The Summit Therapeutics Inc. (SMMT) operating income growth is N/A, compared to the industry median of 1.0% and the 5-year historical average of 44.1%.
What is the Summit Therapeutics Inc. (SMMT) EPS (Earnings Per Share) growth?
The Summit Therapeutics Inc. (SMMT) EPS growth is (93.6%), compared to the industry median of (20.6%) and the 5-year historical average of 128.3%.
What is the Summit Therapeutics Inc. (SMMT) Free Cash Flow (FCF) growth?
The Summit Therapeutics Inc. (SMMT) Free Cash Flow growth is 120.3%, compared to the industry median of (1.2%) and the 5-year historical average of 45.9%.